Subscribe to Newsletter
Manufacture Facilities, Technology and Equipment

Making Sense of Anti-Sense Oligo Facility Planning

sponsored by CRB

December 11, 2019
12pm EST

One of the great advantages of solid phase Oligo synthesis is its scalability. We’ll discuss how to right-size a facility for current needs, but minimize the facility impact of an increase in manufacturing throughput to take advantage of the synthesis platform’s scalability.

Learning Objectives

  • Equip listeners to swiftly devise a facility layout using a starting batch size/throughput and a projected batch size/throughput, considering applicable code implications.

Available On-Demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine